The EDITSCD Consortium will organize regular internal meetings to share and communicate the results. In addition, through regular conferences, seminars, and institutional events, the EDITSCD Consortium will establish external communication to disseminate the results widely.
ERN-EuroBloodNet and the EDITSCD Consortium is launching the seventh webinar of the series of webinars regarding gene therapy and genome [...]
A Scientific meeting will be held on December 16th, 2026 on Teams with all Consortium members to present ongoing experiments and updated [...]
ERN-EuroBloodNet and the EDITSCD Consortium is launching the sixth webinar of the series of webinars regarding gene therapy and genome [...]
After four years of project, the Consortium will meet in person on September 8th, 2026 to debrief. A summary of [...]
ERN-EuroBloodNet and the EDITSCD Consortium is launching the fifth webinar of the series of webinars regarding gene therapy and genome [...]
A Scientific meeting will be held on June 5th, 2026 on Teams with all Consortium members to present ongoing experiments and updated [...]
ERN-EuroBloodNet and the EDITSCD Consortium is launching the fourth webinar of the series of webinars regarding gene therapy and genome [...]
The 3rd edition of the CRISPR MEDiCiNE Conference will take place in Copenhagen, Denmark from April 13th - 16th 2026. Marcello Maresca and Ayal Hendel will give [...]
A Scientific meeting has been held on March 16th, 2026 on Teams with all Consortium members to present ongoing experiments and updated [...]
ERN-EuroBloodNet and the EDITSCD Consortium is launching the third webinar of the series of webinars regarding gene therapy and genome [...]
A Scientific meeting has been held on November 27th, 2025 on Teams with all Consortium members to present ongoing experiments and updated [...]
ERN-EuroBloodNet and the EDITSCD Consortium is launching the second webinar of the series of webinars regarding gene therapy and genome [...]
Stay tuned! ERN-EuroBloodNet and the EDITSCD Consortium are launching a series of webinars aimed at providing an overview of gene [...]
The 18th annual Sickle Cell in Focus conference will be held in a virtual format and will provide a world-class [...]
After three years of project, the Consortium met in person on September 15th and 16th, 2025 to debrief. A summary [...]
The European Hematology Association (EHA) will host the EHA 2025 Congress in Milan from June 12 to 15, 2025. The scientific [...]
A Scientific meeting has been held on May 30th, 2025 on Teams with all Consortium members to present ongoing experiments and updated [...]
A Scientific meeting was held on March 19th, 2025 on Teams with all Consortium members to present ongoing experiments and updated EDITSCD results.
A Scientific meeting was held on December 4th, 2024 on Teams with all Consortium members to present ongoing experiments and updated EDITSCD results.
The ERN-EuroBloodNet Progress Meetings, are organized every autumn by the ERN-EuroBloodNet Coordination team, to promote networking among the haematologic stakeholders with the aim of identifying needs [...]
Members of EDITSCD Consortium will join the Hemoglobin switching meeting in Puerto Rico to discuss about haemoglobinopathies, globin gene expression, [...]
Members of EDITSCD Consortium will join the Synthego Seminar in Paris to discuss sgRNA manufacturing, CRISPR nucleases for therapeutic development [...]
31th annual congress of ESGCT This year ESGCT will take place at Rome. Members of EDITSCD Consortium will join the meeting!
Congress Europe 2024 The World Orphan Drug Congress is the largest and most established orphan drugs & rare diseases meeting of its [...]
Learn more about sickle cell anemia, a genetic disease that affects millions of people worldwide, with the screening of the [...]
19th Annual Sickle Cell & Thalassaemia Conference Hosted by the Academy for Sickle Cell and Thalassaemia (ASCAT), in collaboration with the [...]
This project has received funding from the European Union’s Horizon Europe research and innovation programme under grant agreement No 101057659